New Market Study, "XEPTAGEN SpA - Product Pipeline Analysis, 2013 Update", Has Been Published
Xeptagen SpA (Xeptagen) is a healthcare company. The company discovers novel molecular markers to produce diagnostic kits for the early detection, monitoring, and screening of cancerous cells. Its products include HEPA AB, HEPA IC, HEPA AFPIC, COLONIC, PROSTATEIC and SCCALISA. Xeptagen utilizes combinatorial proteomic technology platform to discover specific tumor markers. The company develops an optoelectronic biochip for the determination of tumor molecular markers. It conducts research on developing biochips for the simultaneous detection of biomarkers-IgM immunecomplexes, which are associated...
View full press release